A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP). - IMPALA-2
An Open-label, non-controlled, multicenter, Pilot clinical Trial of Inhaled Molgramostim in subjects with Antibiotic-resistant non-tuberculosis mycobacterial (NTM) infection - OPTIMA - SAV008-01 - Pilot clinical trial of inhaled Molgramostim
A Randomised, Double-Blind, Placebo-Controlled Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary AlveoLAr Proteinosis Patients - IMPALA
100 Clinical Results associated with Savara ApS
0 Patents (Medical) associated with Savara ApS
100 Deals associated with Savara ApS
100 Translational Medicine associated with Savara ApS